This article is more than 5 years old. Information may no longer be current.
Top five articles from annual AAO meeting
Click Here to Manage Email Alerts
In October, the American Academy of Ophthalmology held its annual meeting in Chicago, featuring presentations on the latest advancements in the specialty.
Here are the top five most-read stories from Healio.com/OSN’s coverage of the meeting:
Low-dose atropine effective in slowing myopia progression
Multiple studies comparing different doses of atropine have shown a 0.01% dose has slowed myopia progression more so than doses of 0.05% or 0.1%. Read more.
Younger patients with high-risk melanoma benefit from adjuvant Sutent
Sunitinib in the adjuvant setting is associated with greater overall survival in high-risk patients with uveal melanoma, especially younger patients. Read more.
Anatomic results maintained at end of brolucizumab studies
Brolucizumab maintained non-inferiority to aflibercept regarding best corrected visual acuity change at week 96, which was the end of the HAWK and HARRIER trials. Read more.
Ophthalmology on the road to value-based care
Transitioning from a volume-based system to a value-based one is the future of medicine in this country, and ophthalmology is a specialty best-suited to lead that charge. Read more.
Thyroid eye disease therapy shows promise
Teprotumumab, an IGF-1 receptor antagonist antibody, demonstrated improvement of double vision in patients with thyroid eye disease. Read more.